Giuseppe Tonini
机构: Professore ordinario di Oncologia, Università Campus Bio-Medico di Roma
每年引用次数
引用次数
引用: 32,292
H-指数: 84
I10-指数 : 375
出版物: 886
Current concepts on myocardial depressant factor.
Sigfrido I , Giuseppe T , Pasquale M , Marco S
Polish journal of medicine and pharmacy 21 ( 1) 53
1989
Atypical chronic head and neck pain: don't forget Eagle's syndrome.
F. Salvinelli , F. Bressi , M. Casale , B. Vincenzi
European Review for Medical and Pharmacological Sciences 12 ( 2) 131 -133
11
2008
Cell cycle alterations and lung cancer.
A. Baldi , S. Angeletti , G. Schiavon , B. Vincenzi
Histology and Histopathology 21 ( 4) 423 -435
52
2006
Bevacizumab (BV) in combination with folfoxiri compared to BV plus folfiri as first-line treatment of metastatic colorectal cancer (MCRC): preliminary safety results of the tribe study bu the Gruppo Oncologico Nord-Ovest (GONO)
M. Andreuccetti , S. Cupini , M. Banzi , F. Loupakis
12th National Congress of Medical Oncology (AIOM). 10
2010
Genetic modulation of the LET-7 micro-RNA binding to KRAS 3’-untranslated region (3’-UTR) impacts on survival of metastatic colorectal cancer (MCRC) patients (pts) with unresponsive disease to salvage cetuximab-irinotecan
P. Giordani , P. Alessandroni , V. Catalano , B. Vincenzi
11th National Congress of Medical Oncology (AIOM) 20 458 -464
2009
PML expression in soft tissue sarcoma: prognostic value in alkilating agents/anthracyclin based first line therapy
G. Badalamenti , A. Onetti Muda , S. Rossi , F. Grosso
convegno nazionale AIOM
2010
Loss of PTEN expression in colorectal cancer (CRC) metastases (METS) predicts lack of activity of cetuximab plus irinotecan treatment
I. Stasi , L. Pollina , N. Funel , G. Schiavon
10th World Congress on Gastrointestinal Cancer (ESMO International Symposium) 19 14 -14
2008
Correlation of BRAF wild-type status (WT) in primary colorectal tumors with BRAF status in related metastatic sites: Implications for treatment with anti-EGFR antibodies
B. Vincenzi , F. Loupakis , Alfredo Falcone , D. Santini
2010 Gastrointestinal Cancers Symposium (ASCO - GI).
2
2010
Cigarettes smoking habit may induce a reduced efficacy of cetuximab-based treatment in advanced colorectal cancer patients
F. L. Rojas Llimpe , B. Vincenzi , F. Loupakis , G. G. Baldi
10th National Congress of Medical Oncology (AIOM)
2008
KRAS codon 61, 146 and BRAF V600E mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer
I. Stasi , K. Bencardino , V. Catalano , Chiara Cremolini
11th National Congress of Medical Oncology (AIOM) 20
2
2009
Prognosis and chemotherapy sensitivity of metastatic biliary cancers according to primary tumor site
L. Ginocchi , V. Virzì , E. Vasile , Alfredo Falcone
12th World Congress on Gastrointestinal Cancer (ESMO Conference). 21
2010
Is a new line with cetuximab re treatment feasible and active in metastatic colorectal cancer (CRC) patients
B. Vincenzi , A Falcone , D. Santini , E. Maiello
11th National Congress of Medical Oncology (AIOM) 20
2009
PML as a potential predictive factor of efficacy of oxaliplatin based first line chemotherapy in colorectal cancer patients
O. Venditti , A. Onetti Muda , B. Vincenzi , F. Loupakis
Annals of Oncology 20 67 -67
2009
Prevention of radiotherapy-induced emesis.
A. Baldi , R. Dangelillo , B. Vincenzi , D. Santini
Journal of Experimental & Clinical Cancer Research 22 ( 1) 17 -20
33
2003
Chondrosarcoma of the iliac wing in Von Hippel-Lindau disease.
A. Marinozzi , S. A. Barnaba , N. Papapietro , V. Denaro
Journal of Experimental & Clinical Cancer Research 26 ( 4) 599 -601
6
2007
The antineoplastic treatment in the elderly.
R. M. D'angelillo , B. Vincenzi , D. Santini , A. La Cesa
Clinica Terapeutica 153 ( 3) 207 -215
3
2002
Methodological issues and first results of a record linkage between AIDS and Cancer Registries in Italy
L. Mangone , D. Balzi , F. Pannelli , L. Gafà
Epidemiologia e prevenzione 24 ( 3) 109 -116
2
2000
The prevention of vomiting due to antineoplastic chemotherapy in the elderly cancer patient
B. Vincenzi , D. Santini , S. Di Cosimo , G. Gravante
Minerva Medica 90 205 -209
1999
P30.02 Assessing SIADH (Syndrome of Inapproriate Antidiuretic Hormone Secretion) Management and Outcome Among Lung Cancer Patients: The Assert Trial
M. Tiseo , F. Cognetti , M. Torniai , E. Rijavec
Journal of Thoracic Oncology 16 ( 3)
2021
Novel drugs, familiar interactions: ciprofloxacin may increase exposure to the RET inhibitor pralsetinib.
M. Russano , B. Vincenzi , D. Santini , G. Tonini
Annals of Oncology 32 ( 6) 811 -813
2021